DIPHANTE 100 mg, tablet quadrisectable 100 tablets
Active ingredients: Phenytoin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Tablet quadrisectable100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DIPHANTE 100 mg, comprimé quadrisécable
- Pharmaceutical form
- comprimé quadrisécable
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 100 comprimé(s)
- Marketing authorisation holder
- KELA PHARMA (BELGIQUE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63715217CIP73009261CIP133400930092613Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHÉNYTOÏNE SODIQUEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.